https://doi.org/10.4081/hmr.v2i7.420

Progress in the treatment of diffuse large B-cell lymphomas: a German perspective

Vol. 2 No. 7: New Insights in Hematology, Venice (Italy), May 14-17, 2006
Published: June 8, 2009
Abstract Views: 162
PDF: 242
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

M Pfreundschuh
support@pagepress.org
Young good-prognosis patients comprise the low and low-intermediate risk group (risk factor 0 and 1 according to the age-adjusted IPI) while poor-prognosis patients comprise the high-intermediate and high risk group (≥2 risk factors). Optimum treatment responses in young good-prognosis patients have so far been achieved with 6 cycles of a CHOP-like chemotherapy in combination with the anti-CD20 antibody rituximab. Using this therapeutic approach, 3-year event-free survival rates of >90% and overall survival of >97% can be achieved in a very favorable subgroup (patients without IPI risk factor and no bulky disease), while further improvement is warranted for the less favorable subgroup (IPI=I and/or bulky disease; 3-year event-free survival: 77%).

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Pfreundschuh, M. (2009). Progress in the treatment of diffuse large B-cell lymphomas: a German perspective. Hematology Meeting Reports (formerly Haematologica Reports), 2(7). https://doi.org/10.4081/hmr.v2i7.420
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).